// App-Quantinova.ai

: Mepolizumab in patients ≥3 exacerbations and eosinophil count ≥300 cells/µL

Researchers

Presenter

  • Steven Yancey

Principal Investigators

  • Frank C Albers

  • Eric S Bradford

  • Oliver N Keene

  • Robert Price

Medical Centers

  • Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, United States.

  • Respiratory Medical Franchise, GSK, Research Triangle Park, NC, United States,

  • Clinical Statistics, GSK, Stockley Park, Uxbridge, Middlesex, United Kingdom,

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01691521

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved